Navina, the developer of an AI-powered clinical platform for primary care, secured $15 million in Series A funding led by Vertex Ventures Israel. Schusterman Family Investments and existing investor Grove Ventures also joined the round. This brings the company’s total funding to date to $22 million, raised within 12 months after commercial launch. The additional funding will allow Navina to accelerate investment in its AI technology, and expand within physician groups and the enterprise healthcare market. Read more.
Navina Secures $15M in Series A
